Original Research
Published on 16 Jul 2024
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience
in Antimicrobials, Resistance and Chemotherapy
- 1,731 views
- 1 citation